• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
How often are parenteral anticoagulants administered by parents?家长们多久给孩子注射一次肠外抗凝剂?
J Thromb Haemost. 2022 Dec;20(12):2746-2750. doi: 10.1111/jth.15887. Epub 2022 Oct 5.
2
Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).胃肠外抗凝剂:美国胸科医师学会循证临床实践指南(第8版)
Chest. 2008 Jun;133(6 Suppl):141S-159S. doi: 10.1378/chest.08-0689.
3
Parenteral anticoagulation in ambulatory patients with cancer.癌症门诊患者的胃肠外抗凝治疗
Cochrane Database Syst Rev. 2017 Sep 11;9(9):CD006652. doi: 10.1002/14651858.CD006652.pub5.
4
Parenteral anticoagulation in ambulatory patients with cancer.癌症门诊患者的胃肠外抗凝治疗
Cochrane Database Syst Rev. 2014 Dec 10(12):CD006652. doi: 10.1002/14651858.CD006652.pub4.
5
Harmful medication errors involving unfractionated and low-molecular-weight heparin in three patient safety reporting programs.在三个患者安全报告项目中,涉及普通肝素和低分子量肝素的有害用药错误。
Jt Comm J Qual Patient Saf. 2010 May;36(5):195-202. doi: 10.1016/s1553-7250(10)36032-6.
6
Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation.对无抗凝治疗或预防指征的癌症患者进行肠外抗凝。
Cochrane Database Syst Rev. 2011 Apr 13(4):CD006652. doi: 10.1002/14651858.CD006652.pub3.
7
Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation.对无抗凝治疗或预防指征的癌症患者进行肠外抗凝。
Cochrane Database Syst Rev. 2011 Jan 19(1):CD006652. doi: 10.1002/14651858.CD006652.pub2.
8
Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.肠外抗凝剂:抗血栓治疗与血栓预防,第 9 版:美国胸科医师学会循证临床实践指南。
Chest. 2012 Feb;141(2 Suppl):e24S-e43S. doi: 10.1378/chest.11-2291.
9
Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulation.对于无其他抗凝指征的癌症患者,采用肠外抗凝以延长生存期。
Cochrane Database Syst Rev. 2007 Jul 18(3):CD006652. doi: 10.1002/14651858.CD006652.
10
Slow versus fast subcutaneous heparin injections for prevention of bruising and site pain intensity.皮下缓慢注射肝素与快速注射肝素预防瘀斑和注射部位疼痛强度的比较。
Cochrane Database Syst Rev. 2021 Jun 8;6(6):CD008077. doi: 10.1002/14651858.CD008077.pub6.

引用本文的文献

1
Heparin-Induced Thrombotic Thrombocytopenia (HITT) and Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT): Similar but Different.肝素诱导的血栓性血小板减少症 (HITT) 和疫苗诱导的免疫性血栓性血小板减少症 (VITT):相似但不同。
Methods Mol Biol. 2023;2663:405-415. doi: 10.1007/978-1-0716-3175-1_26.

本文引用的文献

1
Heparin: The Journey from Parenteral Agent to Nasal Delivery.肝素:从肠外给药到鼻腔给药的历程。
Semin Thromb Hemost. 2022 Nov;48(8):949-954. doi: 10.1055/s-0042-1749395. Epub 2022 Jun 22.
2
Successful Treatment of Vaccine-Induced Immune Thrombotic Thrombocytopenia in a 26-Year-Old Female Patient.成功治疗 26 岁女性疫苗诱导免疫性血栓性血小板减少症。
Acta Haematol. 2022;145(2):210-213. doi: 10.1159/000519451. Epub 2021 Oct 6.
3
Antithrombotic Therapy for Stroke Patients with Cardiovascular Disease.心血管疾病患者的卒中抗栓治疗。
Semin Neurol. 2021 Aug;41(4):365-387. doi: 10.1055/s-0041-1726331. Epub 2021 Apr 13.
4
Heparin-induced thrombocytopenia: pathophysiology, diagnosis and treatment.肝素诱导的血小板减少症:病理生理学、诊断与治疗。
Expert Rev Hematol. 2021 Apr;14(4):335-346. doi: 10.1080/17474086.2021.1905512. Epub 2021 Mar 30.
5
Venous Thromboembolism Risk and Thromboprophylaxis Assessment in Surgical Patients Based on Caprini Risk Assessment Model.基于Caprini风险评估模型的外科患者静脉血栓栓塞风险及血栓预防评估
Risk Manag Healthc Policy. 2020 Nov 10;13:2545-2552. doi: 10.2147/RMHP.S272852. eCollection 2020.
6
Potentially Inappropriate Treatments at the End of Life in Nursing Home Residents: Findings From the PACE Cross-Sectional Study in Six European Countries.终末期养老院居民潜在不适当治疗:来自六个欧洲国家 PACE 横断面研究的结果。
J Pain Symptom Manage. 2021 Apr;61(4):732-742.e1. doi: 10.1016/j.jpainsymman.2020.09.001. Epub 2020 Sep 8.
7
Regression of Atherosclerosis in ApoE-/- Mice Via Modulation of Monocyte Recruitment and Phenotype, Induced by Weekly Dosing of a Novel "Cytotopic" Anti-Thrombin Without Prolonged Anticoagulation.通过每周给予新型“细胞靶向”抗凝血酶而不延长抗凝作用,调节载脂蛋白 E 基因敲除小鼠单核细胞募集和表型,使动脉粥样硬化消退。
J Am Heart Assoc. 2020 Jul 7;9(13):e014811. doi: 10.1161/JAHA.119.014811. Epub 2020 Jul 2.
8
Medications in COVID-19 patients: summarizing the current literature from an orthopaedic perspective.COVID-19 患者的药物治疗:从骨科角度总结当前文献。
Int Orthop. 2020 Aug;44(8):1599-1603. doi: 10.1007/s00264-020-04643-5. Epub 2020 May 22.
9
Septic cavernous sinus thrombosis in a paediatric patient with undiagnosed thrombophilia.一名患有未确诊血栓形成倾向的儿科患者发生感染性海绵窦血栓形成。
BMJ Case Rep. 2019 Oct 30;12(10):e230159. doi: 10.1136/bcr-2019-230159.
10
An obscure case of using apixaban anti-Xa levels in a morbidly obese patient who was nil per os with enterocutaneous fistula.一例使用阿哌沙班的抗Xa水平监测的罕见病例,患者为病态肥胖,因肠皮肤瘘而禁食。
Blood Coagul Fibrinolysis. 2020 Jan;31(1):80-82. doi: 10.1097/MBC.0000000000000864.

家长们多久给孩子注射一次肠外抗凝剂?

How often are parenteral anticoagulants administered by parents?

机构信息

Haematology, Institute of Clinical Pathology and Medical Research (ICPMR), NSW Health Pathology, Westmead Hospital, Westmead, New South Wales, Australia.

Sydney Centres for Thrombosis and Haemostasis, Westmead, New South Wales, Australia.

出版信息

J Thromb Haemost. 2022 Dec;20(12):2746-2750. doi: 10.1111/jth.15887. Epub 2022 Oct 5.

DOI:10.1111/jth.15887
PMID:36129394
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9828405/
Abstract

Parenteral anticoagulants are a class of anticoagulants that need to be administered non-orally, usually by injection or infusion. There are a variety of such agents, but heparin reflects the most frequently used. Being alerted to an error in a prior publication in which the word "parenteral" was inadvertently replaced by the word "parental," it became clear that even experienced authors make such errors, which could then remain undetected by reviewers and editors, thus leading to failure in correction of same before publication. Given this is likely to be a somewhat ongoing error, we undertook a PubMed search of the literature to identify that "parentally administered" anticoagulants, as well as "parental" administration of other compounds, seems to be evident throughout the literature. We hope this report acts to raise awareness and help avoid similar errors in the future.

摘要

肠外抗凝剂是一类需要非口服给予的抗凝剂,通常通过注射或输注给予。有多种此类药物,但肝素反映了最常用的药物。我们注意到之前的一篇出版物中的一个错误,其中“肠外”一词无意中被替换为“父母”一词。显然,即使是经验丰富的作者也会犯这样的错误,这些错误可能会被审稿人和编辑忽略,从而导致在发表前无法纠正这些错误。考虑到这可能是一个持续存在的错误,我们对文献进行了 PubMed 搜索,以确定“肠外给予”的抗凝剂以及其他化合物的“父母”给予在文献中似乎很明显。我们希望本报告能够提高认识,并有助于避免将来出现类似的错误。